![](https://www.pjhegarty.ie/wp-content/uploads/2022/06/1-1-scaled.jpg)
![4](https://www.pjhegarty.ie/wp-content/uploads/2022/06/4-1-scaled.jpg)
The development is a two-phase project at the Dundalk site — The biologics Phase 1 manufacturing facility to produce biologics medicines, and the Phase 2 Vaccines facility.
The site will comprise seven buildings in total across both facilities, including a three-storey manufacturing facility with a floor area of 21,020m²; a 11,051m² laboratory and administration building with a mechanical penthouse over four floors and a two-storey combined utility building (2,230m²) with three 25m high boiler stacks.
The project also includes single-storey electrical building, a single storey security building, and a wastewater treatment plant to service all facilities.
![3-797x604](https://www.pjhegarty.ie/wp-content/uploads/2022/06/3-797x604-1.jpg)